Finance

Lists
CPH:TSE
Cipher Pharmaceuticals Inc
13,70 CAD
+0,37%
(+0,050) 1D
9-окт., 15:07:05 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for CPH...
Open
13,65 CAD
High
13,75 CAD
Low
13,65 CAD
Mkt. cap
346,56 млн
Avg. vol.
24,66 миң
Volume
14,02 миң
P/E ratio
8,58
52-wk high
20,56 CAD
52-wk low
12,48 CAD
EPS
1,60 CAD
Beta
-0,14
Shares outstanding
25,42 млн
No. of employees
43
Open
13,65 CAD
High
13,75 CAD
Low
13,65 CAD
Mkt. cap
346,56 млн
Avg. vol.
24,66 миң
Volume
14,02 миң
P/E ratio
8,58
52-wk high
20,56 CAD
52-wk low
12,48 CAD
EPS
1,60 CAD
Beta
-0,14
Shares outstanding
25,42 млн
No. of employees
43
News stories
From web sources and news partners
About Cipher Pharmaceuticals Inc
CEO-
Employees43
Founded2000
HeadquartersМиссисога, Онтарио, Канада
SectorPharmaceutical industry
Last report
2026-ж., 12-авг.
Fiscal period
Q2 2026
- / -
Revenue / Est. (CAD)
16,81 млн / 18,61 млн
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
12,83 млн
12,22 млн
12,50 млн
12,07 млн
Cost of goods sold
2,35 млн
2,30 млн
2,21 млн
2,37 млн
Cost of revenue
2,35 млн
2,30 млн
2,21 млн
2,37 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,71 млн
3,68 млн
2,90 млн
3,18 млн
Operating expense
5,51 млн
5,49 млн
4,70 млн
4,96 млн
Total operating expenses
7,86 млн
7,79 млн
6,91 млн
7,33 млн
Operating income
4,97 млн
4,43 млн
5,60 млн
4,73 млн
Other non operating income
-
-
-
-
EBT including unusual items
4,26 млн
4,61 млн
4,95 млн
3,64 млн
EBT excluding unusual items
4,13 млн
4,84 млн
4,89 млн
3,90 млн
Income tax expense
-1,24 млн
-8,70 млн
-1,21 млн
-369,00 миң
Effective tax rate
-29,19%
-188,55%
-24,53%
-10,13%
Other operating expenses
-
-
-
-
Net income
5,50 млн
13,31 млн
6,16 млн
4,01 млн
Net profit margin
42,87%
108,95%
49,28%
33,26%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
15,00 миң
Interest expense
-241,00 миң
-109,00 миң
-51,00 миң
-
Net interest expenses
-241,00 миң
-109,00 миң
-51,00 миң
15,00 миң
Depreciation and amortization charges
1,80 млн
1,81 млн
1,81 млн
1,78 млн
EBITDA
6,77 млн
5,95 млн
7,32 млн
6,44 млн
Gain or loss from assets sale
-
-130,00 миң
-57,00 миң
-
AI content may include mistakes. Learn more
Google колдонмолору